AH
Roche Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Alzheimer's Disease Program | Alzheimer's Disease | Various |
| Neurological Disorders Portfolio | Multiple neurological conditions | Various |
| Oncology Pipeline | Various cancer types | Commercial |
| Diagnostic Solutions | Disease prevention and detection | Commercial |
Leadership Team at Roche
DT
Dr. Thomas Schinecker
Chief Executive Officer, Roche Group
DS
Dr. Severin Schwan
Chairman of the Board
AH
André Hoffmann
Vice Chairman of the Board
TG
Teresa Graham
CEO, Roche Pharmaceuticals
MS
Matt Sause
CEO, Roche Diagnostics
DA
Dr. Alan Hippe
Chief Financial Officer
CA
Cristina A. Wilbur
Chief People Officer
CB
Claudia Böckstiegel
General Counsel
DL
Dr. Levi Garraway
Head of Global Product Development and Chief Medical Officer
SH
Silke Hörnstein
Head of Corporate Strategy and Sustainability